This study will look at how dexamethasone and placebo influence radiation fatigue, quality of life and number of treatment days missed during radiation therapy or radiation therapy and chemotherapy for cancer.
Subjects will randomly receive either dexamethasone or placebo and begin the study medication during the midpoint of their radiation treatment. Study medication will be taken for 14 straight days then stopped. Fatigue and quality of life will be measured weekly with short patient completed surveys. The number of breaks taken during radiation treatment will also be tracked. For safety, blood sugar levels will be checked with finger stick blood draws because dexamethasone is known to cause these levels to increase. Study participation will be approximately 3 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
79
oral dexamethasone 4 mg bid for 14 days
oral placebo
University of Arizona
Tucson, Arizona, United States
Fatigue Measured by FACIT-F Version 4 Fatigue Score
To compare the effects of dexamethasone and placebo on radiation fatigue using validated measures
Time frame: 12 weeks
Quality of Life as Measured by FACIT-F Version 4 Well-Being Score
To determine the effect of dexamethasone on QoL and radiation therapy treatment interruption
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.